challenges in the field of parpi treatment for mcrpc
Published 2 years ago • 207 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
2:02
unanswered questions regarding the use of parp inhibitors for patients with mcrpc
-
1:45
the propel clinical trial exploring olaparib plus abiraterone in mcrpc
-
2:26
caspar: the addition of rucaparib to enzalutamide for the treatment of mcrpc
-
17:44
asco 2021: latest on parpi and other treatments for mcrpc
-
1:35
parp inhibitors for the treatment of metastic castration-resistant prostate cancer
-
3:25
life expectancy with prostate cancer diagnosis
-
12:14
20 amazing robot animals that will blow your mind
-
1:15:48
advanced #prostatecancer treatments extended q a | #markscholzmd & #markmoyadmd #pcri
-
5:15
rucaparib and olaparib: two new treatments approved for advanced prostate cancer | pcri
-
1:23
the evolving treatment landscape of mhspc and mcrpc
-
1:34
combination therapies for the treatment of prostate cancer
-
1:53
the evolving role of parp inhibitors in mcrpc
-
3:55
optimal treatment approaches for mcrpc
-
6:46
what is provenge? learn about immunotherapy for prostate cancer
-
1:15
updates in the treatment of castration-resistant prostate cancer
-
2:16
testing the validity of a prognostic model for castration-resistant prostate cancer
-
2:39
prospects and progress of treatments for mcrpc
-
4:56
improving the prognosis for patients with mcrpc
-
3:38
precision medicine in mcrpc
-
3:30
2020 in review: olaparib & rucaparib, fda approval | ask a prostate expert, mark scholz, md
-
3:38
challenges of mri in prostate cancer
-
2:59
niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer